Effects and Response of LY2605541 in Patients With Type 1 Diabetes Mellitus (BIDO)
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see what effect this investigational drug has on the body,
and whether it causes a change to how your body uses fats and sugars as fuel sources.
Phase:
Phase 1
Details
Lead Sponsor:
Translational Research Institute for Metabolism and Diabetes, Florida